Get Early Access To Our
Rapid Therapy Selection™
For Basal Cell Skin Cancer

Now available in the United States as two options: Travera EarlyAccess™ and Travera RTS™
Test ordering is for licensed physicians only.

Travera EarlyAccess™

Travera EarlyAccess™ for Basal Cell Skin Cancer tests live cancer cells from malignant fluids against a predetermined panel of 20 FDA-approved cancer drugs. This option requires that you share the treatment outcome data to help Travera build additional clinical evidence.

  • Turnaround time: 2 days from sample collection

  • Total drugs tested: 20 FDA-approved

  • Sample types: Tissue, Malignant Fluids

Price: $3,500 USD

Travera EarlyAccess™ panel for Basal Cell Skin Cancer includes:

    • Vismodegib (Erivedge)

    • Binimetinib (Mektovi)

    • Bosutinib (Bosulif)

    • Cobimetinib (Cotellic)

    • Dabrafenib (Tafinlar)

    • Dasatinib (Sprycel)

    • Everolimus (Afinitor)

    • Imatinib (Gleevec)

    • Lapatinib (Tykerb)

    • Olaparib (Lynparza)

    • Panobinostat (Farydak)

    • Ponatinib (Iclusig)

    • Regorafenib (Stivarga)

    • Sorafenib (Nexavar)

    • Sunitinib (Sutent)

    • Trametinib (Mekinist)

    • Vandetanib (Caprelsa)

    • Vemurafenib (Zelboraf)

    • Vinblastine (Velban)

    • Vincristine (Oncovin)

Travera EarlyAccess™ is also available through a no-cost, nation-wide clinical study, and other financial assistance is available.
Please call 781-874-0808 or email us for more information.

Travera RTG™

Travera RTS™ tests live cancer cells from malignant fluids against a panel of up to 20 FDA-approved cancer drugs of your choice. Our catalog includes over 100 FDA-approved drugs.

Travera RTS™ includes:

  • Turnaround time: 2 days from sample collection

  • Total drugs tested: up to 20 FDA-approved

  • Sample types: Tissue, Malignant Fluids

Price: $1,000 USD per drug tested

Contact us

Travera offers email and phone support (781-874-0808) to address questions about the test and testing process. Our goal is to bring you hope and an improved outcome. Don't hesitate to contact us anytime; we will respond within 24 hours.